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Abstract
Background: The burden of non-communicable diseases is rising, particularly in low and middle-income countries
undergoing rapid epidemiological transition. In sub-Saharan Africa, this is occurring against a background of infectious
chronic disease epidemics, particularly HIV and tuberculosis. Consequently, multi-morbidity, the co-existence of
more than one chronic condition in one person, is increasing; in particular multimorbidity due to comorbid
non-communicable and infectious chronic diseases (CNCICD). Such complex multimorbidity is a major challenge
to existing models of healthcare delivery and there is a need to ensure integrated care across disease pathways
and across primary and secondary care.
Discussion: The Innovative Care for Chronic Conditions (ICCC) Framework developed by the World Health Organization
provides a health systems roadmap to meet the increasing needs of chronic disease care. This framework incorporates
community, patient, healthcare and policy environment perspectives, and forms the cornerstone of South Africa’s
primary health care re-engineering and strategic plan for chronic disease management integration. However, it does
not significantly incorporate complexity associated with multimorbidity and CNCICD.
Using South Africa as a case study for a country in transition, we identify gaps in the ICCC framework at the micro-,
meso-, and macro-levels. We apply the lens of CNCICD and propose modification of the ICCC and the South African
Integrated Chronic Disease Management plan. Our framework incorporates the increased complexity of treating
CNCICD patients, and highlights the importance of biomedicine (biological interaction). We highlight the patient
perspective using a patient experience model that proposes that treatment adherence, healthcare utilization, and
health outcomes are influenced by the relationship between the workload that is delegated to patients by healthcare
providers, and patients’ capacity to meet the demands of this workload. We link these issues to provider perspectives
that interact with healthcare delivery and utilization.
Summary: Our proposed modification to the ICCC Framework makes clear that healthcare systems must work to
make sense of the complex collision between biological phenomena, clinical interpretation, beliefs and behaviours
that follow from these. We emphasize the integration of these issues with the socio-economic environment to address
issues of complexity, access and equity in the integrated management of chronic diseases previously considered in
isolation.
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Background
Health transition and multi-morbidity
Many low and middle-income countries (LMIC) are
undergoing rapid epidemiological transition with a rising
burden of non-communicable diseases (NCD) [1-6]. In
sub-Saharan Africa, this is occurring against a back-
ground of existing infectious chronic disease (ICD) epi-
demics, including HIV and tuberculosis (TB) [7,8],
which has led authors to coin the term colliding epi-
demics of NCD and ICD [7]. This has been considered
from an epidemiological and health systems perspective
rather than the patient perspective. With HIV becoming
a chronic disease associated with increased life expect-
ancy, multi-morbidity, defined as the co-existence of
more than one chronic condition in one person [9] is in-
creasing. This has been shown to increase complexity in
the management of these co-existing conditions [10]
often resulting in poorer health outcomes, and higher
health care needs and costs [11-13].
In high HIV-burden settings such as South Africa (SA),
the premature ageing effect of HIV-infection [14], in-
creased life expectancy, as well as the increased risk of
dysglycaemia [15] and cardiometabolic disease [16] associ-
ated with some antiretrovirals, contribute to associative
multiple morbidities and new disease constellations in the
population. As a result of the growing problem of comor-
bid non-communicable and infectious chronic disease
(CNCICD) in LMIC, a different pattern of multimorbidity
to that described in high-income countries is emerging,
and it is becoming evident at a younger age; the latter due
to the younger age distribution of HIV-infected persons.
The Innovative Care for Chronic Conditions (ICCC)
Framework developed by the World Health Organization
provides a roadmap for health systems to meet the in-
creasing needs of chronic disease care [17]. The model has
at its centre, a triad of patient and family, community and
health care team. The triad in turn is supported by the lar-
ger health care organisation, community and policy
environment at the meso and macro level respectively.
However, it does not significantly incorporate issues of
multimorbidity, in particular CNCICD. This necessitates a
re-thinking of models of healthcare delivery and health
care policy and planning in order to provide an adequate
primary and secondary care response to the ongoing
health transition. We propose using the case study of
South Africa, a country that is using the ICCC framework
in its strategy to improve chronic disease management, to
highlight the need to extend this framework to include the
lens of multimorbidity and in particular CNCICD. We
identify some gaps in the ICCC Framework at the micro,
meso, and macro levels and propose inclusion of CNCICD
complexity issues including disease interactions, factors
that influence patient behaviour, health care provider
choices and health system characteristics.
Case study: South Africa
Burden of disease
The Global Burden of Disease study demonstrated that
in Southern Africa, whilst HIV and TB rank 1st and 4th
in the top ten causes of morbidity respectively, 50% of
the causes of morbidity are NCD; cerebrovascular dis-
ease is ranked 7th and diabetes is ranked 8th [18]. In
South Africa, morbidity and mortality from diseases of
the circulatory system, neoplasms, endocrine, nutritional
and metabolic disease are increasing [19]. Against this
background, the burden of HIV and TB remain high
with effective antiretroviral therapy (ART), in wide-
spread use in South Africa since 2005/6. There are
limited data on co-morbidities from South Africa. Un-
published data from a retrospective study on CNCICD
using routine electronic databases from a public primary
care clinic in a Cape Town informal township, found
that 19% of HIV-infected patients on ART were receiv-
ing treatment for another chronic disease. Of these, 77%
and 17% had co-existing hypertension and diabetes re-
spectively (Oni, T et al; unpublished). The prevalence of
hypertension and diabetes increased with age but was
notably high in the younger age groups; at 20% and 12%
in the 18-35 year olds rising to 30% and 26% in the
36-45 year olds respectively (Oni, T et al; unpublished).
Another study in HIV-infected persons over 50 years
old in rural South Africa reported that 39% and 51% of
ART-experienced and naïve patients had a co-morbid
chronic disease [20].
Health system
There are two significant reforms occurring within the
South African public health system. Firstly, South Africa is
developing a National Health Insurance (NHI) scheme, a
financing system that aims to provide equitable essential
healthcare to all. The focus in the first 5 years of imple-
mentation is on health system strengthening and a signifi-
cant overhaul of the existing health system delivery
structures will be required. Currently, a minority of the
population receive health care through a private insurance
system. The vast majority of citizens receive care through
a public system, which is free at the primary care level, but
is currently underfunded and overall offers significantly
less access and fewer services. The proposed changes re-
late to infrastructure development, information manage-
ment, and quality improvement with a focus on improving
patient experience as well as ensuring accessible, equitable
and cost effective care. Secondly, the National Department
of Health is re-engineering primary health care to more
effectively and equitably address the growing multiple
disease burden. As part of this reform, NCD management
has been prioritized and a comprehensive strategic plan
to combat NCD proposed. Embedded in this strategic plan
is the need to integrate all chronic disease management
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where possible [21]. Presently, most chronic diseases are
managed in separate disease-specific primary care clinics.
This strategic plan was developed using the health sys-
tems building blocks described in the ICCC Framework
[17]. The ICCC Framework identifies a need to shift
from an acute episodic to a chronic model of care in de-
veloping countries. It speaks to integrated chronic care
including coordination of care from prevention to ter-
tiary care to improve the continuum of care. But since
the inception of the framework in 2002, the epidemi-
ology of population health has transitioned in the con-
text of SA. The framework does not incorporate the
concept of multimorbidity and particularly CNCICD. In
addition, while it recognizes the central role of patients,
family, and the community with an emphasis of the need
for lifestyle and behavior change for effective manage-
ment of chronic diseases, it does not incorporate the fac-
tors that influence these lifestyle choices and ability to
effect behavior change and medication adherence. Sev-
eral studies have proposed frameworks for exploring
multimorbidity. These include examining the interaction
between chronic diseases and the psychosocial environ-
ment [22], understanding patient workload [23] and in-
corporating knowledge of patient coping mechanisms
and self-management skill requirements [24].
We apply the lens of CNCICD and propose a frame-
work that modifies the ICCC and the South African
Integrated Chronic Disease Management (ICDM) plan
to incorporate key components of relevance in countries
like South Africa undergoing health transition. The
proposed modified framework (Figure 1) incorporates
micro-(e.g. individual patients and their interaction
with the health care team), meso-(e.g. health care team
and organisation), macro- (e.g. policies to integrate care)
level factors that influence patient behavior, biological
interactions between co-existing diseases and risk fac-
tors, contributing to increasing complexity; with implica-
tions on the health provider capability to manage these
conditions and health system policies. We further use
South Africa as a case study to demonstrate gaps identi-
fied by the application of our proposed ICCC Frame-
work modification.
Figure 1 Conceptual modification of the WHO ICCC Framework: ICCC Framework represented within shaded square and modification
represented by arrows and text bubbles.
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Discussion
Conceptual modification to the ICC framework
The conceptual modification builds on earlier clinical
work that develops multimorbidity as a problem, and
theoretical work [23,25] that proposes that patient work-
load and capacity interact to affect healthcare utilization
and health outcomes. The proposed modification also
emphasizes the importance of biomedicine (disease-dis-
ease interaction). It links this to patient and provider
perspectives that interact with healthcare systems: it
makes clear that healthcare systems must work to make
sense of the collision between biological phenomena,
their clinical interpretation, the beliefs and behaviours
and their feedback on individual health outcomes,, and
with the socio-economic environment to address issues
of access, equity and cost effectiveness.
Biological interaction
Challenges associated with the management of multi-
morbidity between chronic infectious, particularly HIV
and TB and NCD have increasingly been reported in
LMIC [7,26]. These multimorbidities may arise at differ-
ent levels. At the individual level, multimorbidity some-
times cluster as a result of shared risk factors (e.g.
obesity, diabetes and hypertension), or as complications
of other diseases (e.g. chronic kidney disease leading to
cardiovascular disease and vice versa). In addition, these
previously distinct entities of NCD or ICD increasingly
share the same upstream determinants of poverty and
low socio-economic status [7]. CNCICD may interact
with respect to clinical manifestation (studies suggest
co-morbid type 2 diabetes may alter clinical manifest-
ation of TB [27]), screening and diagnostic algorithms,
susceptibility, and prognosis. In addition, challenges due
to shared pathophysiology and toxicities, pharmaco-
logical interactions between treatments that may reduce
efficacy or increase toxicity, and the bidirectional nature
of some of these relationships (a long term sequelae of
TB is chronic obstructive pulmonary disease (COPD);
which itself increases the risk of TB), is important to
understand [28]. These cases and their management are
often more complex requiring more specialized, but
paradoxically ‘minimally disruptive’ services [25]; chal-
lenging in under-resourced, over-stretched LMIC health
systems.
In South Africa, most HIV and NCD patients are man-
aged at the primary care level, primarily by nurses, with
support from physicians as required. The colliding epi-
demics of HIV and NCD have highlighted the inadequa-
cies of the existing vertical programs; and lend support
to the call for a better-integrated health service. The
WHO ICCC Framework recommends that health care
workers work with community partners and patient
households to improve health outcomes. Our proposed
modification highlights the different levels of interaction
to be considered with managing co-existing diseases. In
this regard, research to better understand the population-
specific epidemiology of the interactions between disease-
specific morbidities, is required. The planned NHI in
South Africa is an opportunity to integrate chronic HIV,
TB and NCD care whilst ensuring coordination between
chronic and acute services.
Patient perspective
The demographic characteristics of patients with multi
morbidity and CNCICD in LMIC is such that there is a
need to consider the ability of patients to self-manage and
prioritise when they are economically active or have pivotal
social responsibilities or roles in the household. Shippee et
al [23] have set out a model of patient experience that pro-
poses that treatment adherence, healthcare utilization, and
health outcomes are influenced by the relationship between
the workload that is delegated to patients by healthcare
providers (including managing self-care, treatment mo-
dalities, behavior change, and clinic visits), and patients’
capacity to meet the demands of this workload (including
physical and mental functioning, pre-existing health literacy
and family and social support). In the Shippee model,
multimorbidity is likely to both increase workload and
reduce capacity – over time it adds complexity to patient
experiences, and leads to ineffective and inappropriate out-
comes. Notably, the burden of multimorbidity is generally
higher in the poor who often have a lower capacity to deal
with ill health. The workload/capacity balance and patient
input into their overall self-care, contribute to patient
prioritization and choices.
A key component of the South African NHI scheme is
improving the quality of patient experience when acces-
sing health care. We propose that consideration of the
patient-centred experiences should include understand-
ing factors that influence coping mechanisms, patient
choices and prioritization when multiple morbidities
co-exist. This calls for better context-specific measures
of workload and capacity.
Health provider perspective
Analysis of professional-patient encounters in chronic dis-
ease management settings shows that patients consistently
reveal intensification of self-care and self-management
demands, and increasing workload with multiplication of
comorbid conditions [29,30]. In this context, patterns of
healthcare delivery that emphasize minimally disruptive
healthcare [25] are likely to improve treatment adherence
because they focus attention on understanding and en-
gaging with patient preferences, improving capacity, and
reducing workload. Consequently, management decisions
are a process of trade-offs, dependent on the health pro-
vider’s ability to deal with a multiplicity of co-morbidities.
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Multimorbidity and CNCICD requires a shift towards in-
tegrated generalist care, rather than the continued prolif-
eration of specialist roles, because it means that patients
are no longer dependent on a single clinical discipline, but
now need to interact with several. This increases the
organizational and administrative workload placed on pa-
tients and adds problems of workability to that of the ac-
cumulation of complexity proposed by Shippee et al. [23].
The potential challenge of up skilling generalists could be
countered through emphasis on integrated chronic disease
teams. Therefore it is important that evidence from bio-
logical interactions and patient perspectives inform care of
complex patients. A view of achievable health goals and
prioritization of conditions, shared by the chronic disease
team and patient, is desirable to enhance patient satisfac-
tion, their adherence and respect for patient choices and
clinical decisions alike.
Health system perspective
The current vertical chronic disease specific health sys-
tem requires re-consideration in a setting of a high
prevalence of multimorbidity. The South African NCD
strategy comments on the need to integrate chronic in-
fectious and non-communicable diseases although suc-
cessful demonstration remains limited at this point. We
propose extending the concept of integration to incorp-
orate patient perspectives that take into account the
complexity of social determinants of health and the
capacity to respond to ill health. We also advocate the
importance of incorporating the health provider per-
spective into informing the structuring of the health sys-
tem including human capacity to improve management
and outcomes of chronic diseases. One option for inte-
gration is in the community adherence clubs. Presently,
separate HIV and NCD adherence clubs, coordinated by
disease-specific community care workers (CCWs), exist
where patients interact with other patients with similar
chronic diseases, receive health education talks and are
dispensed repeat prescriptions. Integration of training
for CCWs and these clubs would facilitate continuity
of care and easier access to routine prescriptions, and
pilot studies of CCW integration are underway in South
Africa. Another option is the integration of chronic dis-
ease clinics for patients considered to be stable. This
would include integration of screening for other preva-
lent chronic diseases.
With respect to monitoring and evaluation, the Direct
Observed Therapy (DOT) short-course framework for
TB management has demonstrated that a standardized
electronic information management system is crucial to
facilitating effective monitoring and evaluation of the
equity and effectiveness of chronic disease management
systems and interventions. This includes, standardized
indicators to measure single- and multi-morbidity. Pilot
interventions to integrate chronic disease clinic station-
ary are underway in the Western Cape. The Western
Cape province of South Africa conducts annual NCD
audits to assess progress towards identified targets. This
includes an audit of facility equipment, management,
and individual disease management targets. Whilst les-
sons learnt from audits and the DOTs framework pro-
vide a starting point for examination of the health
system model, these approaches do not sufficiently inte-
grate other perspectives. Of note, the patient perspective,
including the acceptability of interventions that take
management of morbidities out the health facilities
and into the home, should be incorporated into the
monitoring and evaluation of the effectiveness and cost
effectiveness of health system policy and interventions.
In addition, the monitoring of equity in health services
and the impact of multimorbidity and health system
changes would be vital to reduce socioeconomic/geo-
graphical inequity gaps.
Summary
The ICCC framework provides a comprehensive frame-
work for integration of chronic disease management and
is the cornerstone of primary health care re-engineering
and the ICDM in South Africa. We argue that it is import-
ant to also take into consideration changing patterns of
morbidity and the increasing prevalence of CNCICD,
particularly in LMIC, using SA as a case study, where
rapidly urbanizing poorer populations are arguably more
susceptible to multimorbidity and the adverse outcomes
that can result. Our proposed modification recommends
incorporating biological interactions, patient and health
provider workload and capacity into the ICCC Framework
to inform primary heath care re-engineering and inte-
grated chronic disease management to optimize health
outcomes. In order to reach the target of a 25% reduction
in mortality due to NCD by 2025 set at the 65th World
Health Assembly, innovative strategies will be required. In
South Africa, the ongoing health care reforms provide an
opportunity to incorporate issues of complexity associated
with multimorbidity and CNCICD into the strategic
objectives of primary care re-engineering and integrated
chronic disease management. Our proposed modification
of the ICCC Framework could also be considered for
dealing with CNCICD in other LMIC undergoing demo-
graphic, epidemiological and health transition.
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